Tomorrow's Drugs Today
evotec
[search1]
  • About us
    • Renovis Merger
    • Senior Management
    • Supervisory Board
    • Scientific Advisory Board
    • Evotec Worldwide
  • Our Platform
    • Fragment-based Drug Discovery
    • Assay Development & Screening
    • Compound Libraries
    • Medicinal Chemistry
  • Our Pipeline
  • Partners
  • Investors
    • Evotec Stock
    • Financial Key Figures Analysts
    • Financial Reports Annual General Meeting
    • SEC Filings Corporate Governance
    • Webcasts Annual Document
  • News & Events
    • Adhoc Releases
    • News Releases
    • Events Calendar
    • Sign up for News & Events
  • Careers
    • Vacancies
    • Life at Evotec
    • Graduate Recruitment
  • Contact Us
  • Deutsch
  • Home
[search1]
We strive to be the premier drug discovery and development partner for pharmaceutical and biotechnology companies
  • Quick Links
  • Renovis Merger
  • Fragment Based Drug Discovery
  • Discovery Projects
  • Clinical Pipeline

Recent News

Jul 03, 2008

Evotec's EVT 101 Well Tolerated in Four Week Higher Repeat Dose Safety Study

May 08, 2008

Evotec Reports First Quarter 2008 Results

Next Event

06 Aug 2008

Half Year Report 2008/Bericht zum ersten Halbjahr 2008

Fragment-based Drug Discovery

World leading drug discovery platform utilising NMR and Biochemical assay technologies

[search3]
  • Search
  • Disclaimer
  • Privacy Policy
  • Imprint
  • Download Center
  • Accessibility
  • RSS

© 2008 Evotec all rights reserved

[search3]